FR5-14023-12314
3 vaccinations
4 coded responses
40 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 541 / WI
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 1 — Pfizer-BioNTech
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-02
- 2021-04-09
- 2021-04-16
-
2021-04-19
Dose 2 — Pfizer-BioNTech
- 2021-04-19
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
-
2021-05-24
Survey response — day 35, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: Menstrual cramps were markedly worse than usual during my latest cycle (previous cycle was happening when I got 2nd shot 4/18-5/21, most recent started 5/20).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-31
-
2021-07-19
Survey response — 3 months, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to work or attend schoolFree text: My dysmenorrhea was substantially worse than usual during my first cycle after the vaccine, but has been gradually returning to normal in the intervening months.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-18
-
2021-12-13
Dose 3 — Moderna
-
2021-12-13
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-14
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-12-15
- 2021-12-16
-
2021-12-17
Survey response — days 1–6 daily, dose 3MedDRA: Intermenstrual bleeding — Feeling: GoodFree text: I had some breakthrough menstrual spotting (I'm about 8 days out from the end of my menses), which is highly unusual for meMedDRA releases: 2024-11 · check-in free text available
- 2021-12-18
- 2021-12-19
- 2021-12-21
- 2021-12-27
- 2022-01-03
- 2022-01-12
-
2022-01-18
Survey response — day 35, dose 3MedDRA: Intermenstrual bleeding — Feeling: GoodFree text: I've had some menstrual spotting outside of my regular cycle, which is highly unusual for me.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-24
- 2022-03-14
- 2022-06-13
- 2022-12-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech | |
| 3 | 2021-12-13 | Moderna | No |
Free text
Release 8 — day 35, dose 2
Symptoms: Menstrual cramps were markedly worse than usual during my latest cycle (previous cycle was happening when I got 2nd shot 4/18-5/21, most recent started 5/20).
Release 9 — 3 months, dose 2
Symptoms: My dysmenorrhea was substantially worse than usual during my first cycle after the vaccine, but has been gradually returning to normal in the intervening months.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): I had some breakthrough menstrual spotting (I'm about 8 days out from the end of my menses), which is highly unusual for me
Release 10 — day 35, dose 3
Symptoms: I've had some menstrual spotting outside of my regular cycle, which is highly unusual for me.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | · | · | ✓ |
| SD | Intermenstrual bleeding | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Intermenstrual bleeding | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release